Patients with severe, persistent asthma (~4%-10% of all asthma cases) have the highest risk of morbidity and mortality. They contribute significantly to the economic burden of asthma and represent an unmet need in asthma therapy.
Chronic obstructive pulmonary disease (COPD) is severely undertreated, as many patients do not receive appropriate maintenance pharmacotherapy and as many as 12 million others are living with undiagnosed COPD. As a result, COPD patients frequently experience exacerbations associated with an accelerated decline in lung function, impaired quality of life, hospitalization, and increased mortality.
Since the publication of Shapiro and colleagues review article on a primary care approach to substance misuse in 2013, patterns of substance use (particularly opioids) has changed so dramatically in the United States that President Trump on October 26, 2017 proclaimed the opioid epidemic a national public health emergency.
On November 13, 2017, the American Heart Association (AHA) and the American College of Cardiology (ACC) jointly announced new clinical practice guidelines for the management of high blood pressure (HBP) in adults.
Certain populations are burdened with an excessively high risk for major adverse cardiovascular events, including those with clinically evident atherosclerotic cardiovascular disease (ASCVD), defined as a history of myocardial infarction, non-hemorrhagic stroke, or systemic peripheral artery disease.
Although many patients with acute appendicitis first present to the emergency room, primary care providers also frequently encounter patients with abdominal pain in their outpatient clinics. Some of these patients may be presenting with early appendicitis.
Parkinson’s disease (PD) treatment is complex and requires the integration of a multi-member healthcare team. However, patients are often challenged with limited access to specialists. In fact, more that 40% of PD patients do not see a neurologist within the first four years of diagnosis.
Twenty-first century technology is now beginning to blend payment with measureable health value management of patient populations, requiring pro-active PHM. More and more, alternative payment models (APMs) are requiring providers to think of PHM beyond their individual patient populations to community-wide consumers of their services; achieving an improved health status across the care continuum.
By now, you have heard of the Medicare reform terms associated with the Medicare Access & CHIP Reauthorization Act of 2015 (MACRA), namely the merit-based incentive payment system (MIPS) and advanced alternative payment models (A-APMs). Beginning in 2019, physicians, physician assistants, nurse practitioners, clinical nurse specialists, and CRNAs paid under a Medicare Physician Fee Schedule (MPFS) will be subject to one of these two new payment methodologies based on measured performance in the preceding two years (2017 for a 2019 payment year).